Why It Matters
The release of advanced measles genome data has significant implications for public health policy across the United States, including in New Hampshire, where healthcare officials monitor infectious disease spread closely. The data will help determine whether the U.S. has lost its official measles elimination status — a milestone achieved in 2000 after decades of widespread vaccination efforts.
Losing elimination status would trigger major consequences for federal public health funding, international health standing, and state-level disease response protocols. The findings could also intensify debates around vaccine policy at a time when measles cases have been climbing nationally.
What Happened
This week, the Centers for Disease Control and Prevention (CDC) published its first large tranche of whole-genome sequencing data from measles viruses that circulated in the United States between January 20, 2025, and January 20, 2026. The release marks a significant step forward after months of delays caused by staffing disruptions at the agency.
The genomic data — which captures the complete genetic blueprint of individual measles viruses — was sequenced as part of a coordinated scientific effort. Researchers at the Broad Institute in Cambridge, Massachusetts, including scientist Katelyn Messer, were among those who sequenced the 1,000 whole measles genomes included in the first data release.
The CDC had withheld the data for several months while a team, significantly reduced by mass layoffs and resignations, worked through the backlog. Scientists familiar with the operation now expect additional data to be released at a faster pace in the coming weeks.
“Start flowing more smoothly at a more rapid cadence,” said Kristian Andersen, an evolutionary virologist at the Scripps Research Institute, describing what he expects from future releases. Andersen is not involved in the CDC’s effort but has been closely following its progress.
By the Numbers
1,000 — The number of whole measles virus genomes sequenced and included in the CDC’s first major data release.
12 months — The timeframe covered by the genomic data, spanning January 20, 2025, to January 20, 2026.
2000 — The year the United States first achieved measles elimination status, following widespread childhood vaccination campaigns.
Several months — The length of time the CDC delayed publication while understaffed teams processed the data following significant workforce reductions.
0 — The number of responses the CDC provided to KFF Health News queries regarding its timeline for publishing the remaining measles data and analyses.
Zoom Out
The release comes amid a broader national conversation about the United States’ measles elimination status. Measles cases surged in 2024 and into 2025, with outbreaks reported in multiple states. Public health officials have warned that sustained domestic transmission — rather than isolated cases imported from abroad — could signal that elimination status has been compromised.
Once the full dataset is publicly available, researchers can conduct initial analyses to determine whether last year’s outbreaks resulted from continuous person-to-person spread across state lines or from separate, unrelated introductions of the virus from other countries. That distinction is critical: continuous domestic spread is the primary marker used to assess whether a country retains elimination status under World Health Organization criteria.
The CDC’s staffing challenges, which contributed to the months-long data delay, reflect a wider pattern of federal public health workforce reductions. As New Hampshire lawmakers continue debating healthcare access issues — including efforts to broaden ‘Right to Try’ protections for chronically ill patients — the capacity of federal agencies to deliver timely public health data remains a key concern at the state level.
Rural communities across the country face particular vulnerability to infectious disease outbreaks due to lower vaccination rates and limited healthcare infrastructure. The New Hampshire Executive Council recently narrowly approved a rural health program contract, underscoring ongoing efforts to shore up healthcare resources in underserved areas.
What’s Next
The CDC is expected to release additional batches of measles genomic data in the coming weeks. Scientists plan to run rapid analyses once the full dataset is publicly available, with initial findings likely to indicate whether the U.S. should be reclassified regarding its measles elimination status.
Public health researchers and federal officials will be watching closely, as any formal determination about elimination status would likely prompt a policy response at both the federal and state levels. The CDC has not provided a specific timeline for completing or publishing its full analysis.